Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
Our industry partners are developing software for automation of Hydrogen Deuterium Mass Spectrometry, which can connect structure, behaviour and function of proteins, for understanding diseases and
-
We are excited to offer a fully funded PhD position at the Faculty of Engineering, Monash University (Australia). This project focuses on developing new algorithms to equip social robots with
-
research often overlooks the complexities of mixed-vehicle environments, and the development of optimal deployment, routing, and charging strategies. This project aims to address these gaps by optimising
-
-time Duration: 4-year fixed-term appointment Remuneration: 4-year scholarship package totalling approximately $47,000 per annum tax exempt (2025 rate) A four year Project Expense and Development package
-
resources to avoid downtime, adjusting dynamically as traffic fluctuates. For researchers and students, this component focuses on developing ML models to predict resource needs, improving load distribution
-
using data extracted from software repositories. This fine-tuning process aims to enable the models to provide answers to queries related to software development tasks. Examples of such queries include
-
these challenges, calling for the development of responsible AI systems that are transparent, trustworthy, and aligned with human values in educational contexts. This PhD project aims to design, develop, and
-
period to a 'developing' country. Total scholarship value $6000 Number offered Two See details Bachelor of Education (Honours) in Secondary Education and Bachelor of Arts Rebecca Having a scholarship has
-
, Melbourne. We are seeking PhD candidates interested in developing methods to assist the formative assessment and improvement of collocated teamwork, by making multimodal activity traces visible and available
-
Seizure prediction algorithms will be developed using the one-of-a-kind ultra-long-term human intracranial EEG dataset obtained from the Neurovista Corporation clinical trial of their Seizure